Drugs and Clinical Trial (Amendment) Rules, 2023
The Union Government passed an amendment to the New Drugs and Clinical Trial Rules (2023).
- It is aimed at promoting clinical research in India and ensuring the conduct of ethical trials.
- Approval time for drugs discovered or developed in India is reduced to 30 days, while for drugs developed outside it is set at 90 days.
- Ethics Committees will monitor trials and determine compensation for adverse events.
- Orphan drugs, treating conditions affecting up to five lakh persons, are defined for the first time.
|
Clinical Trials
|
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 Right to Change Name
- 2 Prevention of Damage to Public Property
- 3 Jan Vishwas (Amendment of Provisions) Act 2023
- 4 Rule 176 vs. Rule 267 of Rajya Sabha
- 5 Digital India Land Records Modernization Programme (DILRMP)
- 6 Right to Silence
- 7 Vibrant Villages Programme
- 8 Bribery Not Protected by Parliamentary Privileges: SC
- 9 SC Directions for Effective Implementation of POSH Act, 2013
- 10 e-Court Phase III
Current Affairs
- 1 Rights of Non-Tribals in Scheduled Areas
- 2 Judicial Recusal
- 3 Data Governance Quality Index (DGQI)
- 4 Article 355
- 5 Governor's Power to Dismiss the Ministers
- 6 Commission of Railway Safety
- 7 Right to Change Name
- 8 Prevention of Damage to Public Property
- 9 Jan Vishwas (Amendment of Provisions) Act 2023
- 10 Rule 176 vs. Rule 267 of Rajya Sabha
